Characterizing the viral dynamics and host immune responses during virus suppression and treatment interruption.

Investigating broadly neutralizing antibody based interventions and autologous neutralizing antibody development.

Expanding Non-Human Primate (NHP) models that faithfully recapitulate HIV-1 latency and rebound.